Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Revenue (2020 - 2025)

Rapid Micro Biosystems' Revenue history spans 6 years, with the latest figure at $7.8 million for Q3 2025.

  • For Q3 2025, Revenue rose 3.08% year-over-year to $7.8 million; the TTM value through Sep 2025 reached $30.5 million, up 16.63%, while the annual FY2024 figure was $28.1 million, 24.57% up from the prior year.
  • Revenue for Q3 2025 was $7.8 million at Rapid Micro Biosystems, up from $7.3 million in the prior quarter.
  • Across five years, Revenue topped out at $8.2 million in Q4 2024 and bottomed at $3.9 million in Q2 2022.
  • The 5-year median for Revenue is $6.1 million (2021), against an average of $6.0 million.
  • The largest annual shift saw Revenue plummeted 37.03% in 2022 before it soared 44.88% in 2023.
  • A 5-year view of Revenue shows it stood at $5.2 million in 2021, then dropped by 16.01% to $4.4 million in 2022, then soared by 44.88% to $6.3 million in 2023, then increased by 29.68% to $8.2 million in 2024, then decreased by 4.62% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Revenue are $7.8 million (Q3 2025), $7.3 million (Q2 2025), and $7.2 million (Q1 2025).